Literature DB >> 21911522

Treatment of painful osteoporotic vertebral compression fractures: a brief review of the evidence for percutaneous vertebroplasty.

S P J Muijs1, A R van Erkel, P D S Dijkstra.   

Abstract

Vertebral compression fractures are the most prevalent complication of osteoporosis and percutaneous vertebroplasty (PVP) has emerged as a promising addition to the methods of treating the debilitating pain they may cause. Since PVP was first reported in the literature in 1987, more than 600 clinical papers have been published on the subject. Most report excellent improvements in pain relief and quality of life. However, these papers have been based mostly on uncontrolled cohort studies with a wide variety of inclusion and exclusion criteria. In 2009, two high-profile randomised controlled trials were published in the New England Journal of Medicine which led care providers throughout the world to question the value of PVP. After more than two decades a number of important questions about the mechanism and the effectiveness of this procedure remain unanswered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911522     DOI: 10.1302/0301-620X.93B9.26152

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  10 in total

1.  Major medical outcomes with spinal augmentation vs conservative therapy.

Authors:  Brendan J McCullough; Bryan A Comstock; Richard A Deyo; William Kreuter; Jeffrey G Jarvik
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

Review 2.  Update of vertebral cementoplasty in porotic patients.

Authors:  Gianluigi Guarnieri; Salvatore Masala; Mario Muto
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

3.  Therapeutic Efficacy of Third-Generation Percutaneous Vertebral Augmentation System (PVAS) in Osteoporotic Vertebral Compression Fractures (OVCFs): A Systematic Review and Meta-analysis.

Authors:  Chunke Dong; Yuting Zhu; Jun Zhou; Liang Dong
Journal:  Biomed Res Int       Date:  2022-05-07       Impact factor: 3.246

4.  Clinical effect evaluation of percutaneous vertebroplasty combined with the spinal external fixator for the treatment of osteoporotic compressive fractures with posterior vertebral defect.

Authors:  Xizheng Song; Wenjun Wang; Yiguo Yan; Jianhong Zuo; Nvzhao Yao; Haiying Lin
Journal:  Eur Spine J       Date:  2014-08-29       Impact factor: 3.134

5.  Percutaneous kyphoplasty combined with the posterior screw-rod system in treatment of osteoporotic thoracolumbar fractures.

Authors:  Jiang Wu; Yong-Qing Xu; Han-Fen Chen; Yong-Yue Su; Min Zhu; Chong-Tao Zhu
Journal:  Indian J Orthop       Date:  2013-05       Impact factor: 1.251

6.  Influence of Nano-HA Coated Bone Collagen to Acrylic (Polymethylmethacrylate) Bone Cement on Mechanical Properties and Bioactivity.

Authors:  Tao Li; Xisheng Weng; Yanyan Bian; Lei Zhou; Fuzhai Cui; Zhiye Qiu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Posterior decompression and occipitocervical fixation followed by intraoperative vertebroplasty for metastatic involvement of the axis.

Authors:  Xinjie Wu; Mingsheng Tan; Yingna Qi; Ping Yi; Feng Yang; Xiangsheng Tang; Qingying Hao
Journal:  BMC Musculoskelet Disord       Date:  2018-01-11       Impact factor: 2.362

8.  Risk factors for tuberculous or nontuberculous spondylitis after percutaneous vertebroplasty or kyphoplasty in patients with osteoporotic vertebral compression fracture: A case-control study.

Authors:  Bo-Wen Zheng; Fu-Sheng Liu; Bo-Yv Zheng; Hua-Qing Niu; Jing Li; Guo-Hua Lv; Ming-Xiang Zou; Zhun Xu
Journal:  Front Surg       Date:  2022-08-18

9.  Tuberculous spondylitis after percutaneous vertebroplasty: A case series of 9 cases.

Authors:  Po-Ju Lai; Jen-Chung Liao; Lih-Hui Chen; Po-Liang Lai
Journal:  Biomed J       Date:  2019-09-12       Impact factor: 4.910

10.  Optimizing computational methods of modeling vertebroplasty in experimentally augmented human lumbar vertebrae.

Authors:  Gavin A Day; Alison C Jones; Ruth K Wilcox
Journal:  JOR Spine       Date:  2020-02-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.